Plexxikon

Scaffold-Based Drug Discovery

  • Cardio-Renal
  • CNS
  • Inflammation
  • Metabolic Disease
  • Oncology
  • Cardio-Renal
  • CNS
  • Inflammation
  • Metabolic Disease
  • Oncology
  • About
    • Management
    • Board of Directors
    • Scientific Advisors
  • Pipeline
    • Cardio-Renal
    • CNS
    • Inflammation
    • Metabolic Disease
    • Oncology
  • Clinical Trials
  • Partners
    • Partnering Opportunities
    • Partnerships
  • Investors
  • News
    • Press Releases
    • Plexxikon in the News
    • Press Kit
  • Careers
  • Contact Us
    • Driving Directions
01/08/2010
Plexxikon Announces First Patient Dosed In Phase 3 Trial Of PLX4032 (RG7204) For Metastatic Melanoma
10/08/2009
Plexxikon Treats Initial Patient With First-in-Class Drug in Phase 1 Trial
09/30/2009
Plexxikon Announces First Patient Dosed in First of Two Pivotal Trials of PLX4032 for Metastatic Melanoma
© Plexxikon 2010     Website design: Hane Chow Inc.